ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Bellavia et al. designed a Lamp2b-IL3 fusion protein enabling exosomes to specifically target CML blasts expressing IL3 receptor, while simultaneously packaging siBCR-ABL for gene silencing.